Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

28.52
+0.44001.57%
Post-market: 28.00-0.5200-1.82%19:30 EDT
Volume:848.79K
Turnover:24.39M
Market Cap:3.24B
PE:-11.48
High:29.30
Open:28.46
Low:28.13
Close:28.08
52wk High:30.06
52wk Low:8.67
Shares:113.58M
Float Shares:108.11M
Volume Ratio:0.61
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4851
EPS(LYR):-2.4315
ROE:-64.03%
ROA:-37.78%
PB:6.17
PE(LYR):-11.73

Loading ...

Craig-Hallum Keeps Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Apr 29

Immunome submits FDA NDA for varegacestat in adult desmoid tumors

Reuters
·
Apr 29

Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults With Desmoid Tumors

THOMSON REUTERS
·
Apr 29

Immunome announces annual shareholder meeting webcast

Reuters
·
Apr 25

Immunome to present Phase 3 RINGSIDE desmoid tumor data in ASCO oral session

Reuters
·
Apr 21

Immunome Announces Oral Presentation of Phase 3 Ringside Data at 2026 Asco Annual Meeting

THOMSON REUTERS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Immunome (IMNM) and Eli Lilly & Co (LLY)

TIPRANKS
·
Apr 17

Immunome (IMNM) Receives a Buy from LifeSci Capital

TIPRANKS
·
Apr 07

Immunome CSO Jack Higgins disposes of $0.2 million common shares

Reuters
·
Apr 04

Immunome CFO Max Rosett disposes of common shares worth 1.4 million

Reuters
·
Apr 04

BRIEF-Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 03

Immunome grants inducement stock options for 188,500 shares to 13 new hires

Reuters
·
Apr 03

Immunome CEO Clay Siegall buys $0.5 million in common shares

Reuters
·
Apr 01

Immunome Director Philip Wagenheim Disposes of Common Shares Worth USD 1,335,000

Reuters
·
Mar 24

Immunome Director Jean Jacques Bienaime Acquires Common Shares

Reuters
·
Mar 12

Immunome Grants 282,000 Inducement Stock Options to New Hires

Reuters
·
Mar 06

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Mar 06

Stock Track | Immunome Inc. Soars 5.43% Intraday on Multiple Positive Analyst Actions

Stock Track
·
Mar 04

Immunome Is Maintained at Overweight by Stephens & Co.

Dow Jones
·
Mar 04

Piper Sandler Sticks to Its Buy Rating for Immunome (IMNM)

TIPRANKS
·
Mar 04